Related Experiment Video

Updated: Jun 10, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain

Lijuan He1, Nadia Shobnam, Kalina Hristova

  • 1Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.

Biochimica Et Biophysica Acta
|August 18, 2010
PubMed

Insights

Transmembrane domains of receptor tyrosine kinases (RTKs) can specifically inhibit mutant RTKs. This finding suggests potential for developing targeted therapies for diseases caused by RTK mutations.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Transmembrane (TM) domains of receptor tyrosine kinases (RTKs) are crucial for signal transduction.
  • The specificity of RTK TM domain interactions in mammalian membranes requires further investigation.

Purpose of the Study:

  • To investigate the inhibitory potential of RTK TM domains on pathogenic RTK mutants.
  • To assess the specificity of TM domain interactions in inhibiting mutant receptor tyrosine kinases.

Main Methods:

  • Examined heterodimer formation between full-length RTKs and their TM domains.
  • Assessed the phosphorylation levels of RTK mutants upon co-expression with specific TM domains.

Main Results:

  • The Neu/V664E TM domain specifically inhibited the phosphorylation of full-length Neu/V664E.
  • Wild-type Neu TM domain did not inhibit Neu/V664E phosphorylation.
  • Neu/V664E TM domain did not affect FGFR3/A391E phosphorylation, indicating specificity.

Conclusions:

  • RTK TM domains exhibit specific interactions that can be leveraged for therapeutic purposes.
  • TM domain peptides show promise as targeted inhibitors for mutant RTKs, offering a potential new therapeutic strategy.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...